WallStreetZenWallStreetZen

NASDAQ: PAHC
Phibro Animal Health Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Phibro Animal Health revenue was $1.11B for the trailing 12 months ending Dec 31, 2024, with 29.7% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $309.3M, up 18.7% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PAHC annual revenue was $1.0B, with 4.1% growth year-over-year.

PAHC past revenue growth

How has PAHC's revenue growth performed historically?

Company
12.63%
Industry
10.38%
Market
20.68%
PAHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PAHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PAHC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PAHC revenue history

Current Revenue
$1.1B
Current Earnings
$19.3M
Current Profit Margin
1.7%
PAHC's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when PAHC announces revenue.

PAHC Revenue History By Year

PAHC Yearly RevenuePAHC RevenuePAHC ChangePAHC Revenue Growth
2024-06-30$1.02B$39.79M+4.07%
2023-06-30$977.89M$35.63M+3.78%
2022-06-30$942.26M$108.91M+13.07%
2021-06-30$833.35M$33.00M+4.12%
2020-06-30$800.35M-$27.64M-3.34%
2019-06-30$828.00M$8.01M+0.98%
2018-06-30$819.98M$55.70M+7.29%
2017-06-30$764.28M$12.76M+1.70%
2016-06-30$751.53M$2.94M+0.39%
2015-06-30$748.59M$56.68M+8.19%
2014-06-30$691.91M$38.76M+5.93%
2013-06-30$653.15M-$950.00k-0.15%
2012-06-30$654.10M$35.77M+5.78%
2011-06-30$618.33MN/AN/A

1 of 1

Phibro Animal Health Revenue FAQ

What was PAHC's revenue last quarter?

On Invalid Date, Phibro Animal Health (NASDAQ: PAHC) reported Q4 2024 revenue of $309.26 million up 23.73% year over year. In the same quarter last year, Phibro Animal Health's revenue was $249.94 million.

What was Phibro Animal Health's revenue in 2024?

Phibro Animal Health's annual revenue for the twelve months ending Jun 30, 2024 was $1.02 billion, a 4.07% increase year over year.

How much does Phibro Animal Health make in a day?

Based on Phibro Animal Health annual revenue for the past five years, PAHC makes an average of $2,504,949.59 per day.

What was Phibro Animal Health's annual revenue growth in the past year?

As of Q2 2025, Phibro Animal Health's revenue has grown 12.63% year over year. This is 2.26 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. Phibro Animal Health's revenue in the past year totaled $1.11 billion.

How much does Phibro Animal Health make in a year?

Phibro Animal Health's revenue by year for the past five years is:
  • Phibro Animal Health's revenue for the twelve months ending Jun 30, 2024 was $1.02 billion, a 4.07% increase year over year.
  • Phibro Animal Health's annual revenue for Jun 30, 2023 was $977.89 million, a 3.78% increase from 2022.
  • Phibro Animal Health's annual revenue for 2022 was $942.26 million, a 13.07% increase from 2021.
  • Phibro Animal Health's annual revenue for 2021 was $833.35 million, a 4.12% increase from 2020.
  • Phibro Animal Health's annual revenue for 2020 was $800.35 million, a 3.34% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.